Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
CN Stock MarketDetailed Quotes
603881 Shanghai AtHub
- 33.47
- -1.37-3.93%
Not Open Apr 1 15:00 CST
20.04BMarket Cap151.45P/E (TTM)
34.49High33.30Low484.60KlotVolume34.45Open34.84Pre Close1.64BTurnover8.10%Turnover Ratio151.45P/E (Static)598.65MShares44.4152wk High6.21P/B20.04BFloat Cap11.7352wk Low38.32Limit Up598.65MShs Float44.93Historical High31.36Limit Down3.42%Amplitude3.39Historical Low0.09Dividend TTM33.76Avg Price263.70KlotAsk0.26%Div YieldTTM100Lot Size192.59KlotBid
Shanghai AtHub Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 11.57%1.72B | 6.03%1.18B | 4.33%778.38M | 2.51%381.4M | 5.96%1.54B | 1.99%1.12B | 4.74%746.05M | 8.61%372.04M | 16.88%1.46B | 27.92%1.09B |
| Operating revenue | 11.57%1.72B | 6.03%1.18B | 4.33%778.38M | 2.51%381.4M | 5.96%1.54B | 1.99%1.12B | 4.74%746.05M | 8.61%372.04M | 16.88%1.46B | 27.92%1.09B |
| Other operating revenue | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- |
| Total operating cost | 5.86%1.45B | 5.30%1.05B | 3.20%690.04M | 1.64%337.38M | 3.18%1.37B | -2.05%998.95M | -0.46%668.63M | -0.13%331.93M | 20.78%1.33B | 37.31%1.02B |
| Operating cost | 8.39%1.19B | 9.33%867.41M | 7.47%566.21M | 5.68%277.65M | 5.75%1.1B | -0.50%793.36M | 1.26%526.87M | 2.02%262.73M | 25.78%1.04B | 48.37%797.36M |
| Operating tax surcharges | 8.08%1.58M | 6.18%989.67K | 8.09%656.99K | -20.52%346.44K | -7.34%1.46M | -19.79%932.09K | -27.89%607.79K | 55.08%435.88K | 46.68%1.57M | 39.66%1.16M |
| Operating expense | 68.55%4.38M | 35.66%3.29M | 12.46%1.75M | 9.21%716.88K | 1.61%2.6M | -16.91%2.43M | -9.61%1.55M | 1.46%656.43K | -31.05%2.56M | -4.48%2.92M |
| Administration expense | 8.60%74.66M | -19.63%42.6M | -15.80%30.38M | -13.50%11.46M | 2.14%68.75M | 4.42%53.01M | 3.64%36.08M | -18.81%13.25M | 3.74%67.31M | 2.92%50.76M |
| Financial expense | -25.07%98.88M | -23.25%75.21M | -21.35%53.29M | -19.00%28.03M | -15.62%131.96M | -19.07%98M | -18.84%67.75M | -19.11%34.6M | 0.18%156.38M | 9.99%121.09M |
| -Interest expense (Financial expense) | -22.89%106.12M | -21.91%79.94M | -20.91%55.83M | -17.11%29.28M | -14.76%137.62M | -18.59%102.37M | -17.74%70.6M | -19.85%35.32M | 1.39%161.46M | 12.21%125.74M |
| -Interest Income (Financial expense) | -26.26%-7.33M | -5.91%-4.78M | 12.82%-2.59M | 7.71%-1.27M | -7.09%-5.81M | 9.68%-4.52M | -22.15%-2.97M | -2.59%-1.38M | -67.74%-5.42M | -145.37%-5M |
| Research and development | 18.80%87.57M | 21.76%62.38M | 5.58%37.76M | -5.34%19.17M | 8.63%73.71M | 10.10%51.23M | 17.04%35.76M | 36.54%20.25M | 27.67%67.86M | 10.78%46.53M |
| Credit Impairment Loss | 173.68%1.07M | --1.02M | --122.07K | ---- | -2,382.62%-1.45M | ---- | ---- | ---- | -536.41%-58.49K | ---- |
| Asset Impairment Loss | -132.91%-81.43M | ---- | ---- | ---- | -1,092.65%-34.96M | ---- | ---- | ---- | ---2.93M | ---- |
| Other net revenue | -2,081.08%-74.12M | -28.10%14.75M | -40.10%8.24M | -18.82%4.56M | -115.30%-3.4M | 45.53%20.51M | 87.75%13.76M | 181.30%5.61M | 79.14%22.22M | 112.46%14.09M |
| Invest income | 102.12%8.29M | 86.47%5.65M | 12.11%2.68M | 101.37%1.21M | -15.54%4.1M | -31.87%3.03M | -46.25%2.39M | -8.24%602.63K | 38.71%4.85M | --4.45M |
| Asset deal income | -760.82%-10.53M | 47.65%2.35M | -74.28%442.84K | 518.32%442.84K | 123.48%1.59M | 123.25%1.59M | 149.12%1.72M | 92.74%-105.86K | -1,375.26%-6.78M | -890.13%-6.85M |
| Other revenue | -68.99%8.47M | -63.99%5.72M | -48.21%5M | -43.32%2.9M | 0.68%27.32M | -3.71%15.88M | 51.06%9.65M | 82.90%5.11M | 223.82%27.14M | 186.11%16.5M |
| Operating profit | 16.46%192.16M | 6.28%145.44M | 5.93%96.59M | 6.23%48.58M | 12.81%165.01M | 55.81%136.85M | 90.32%91.18M | 276.00%45.73M | -5.83%146.28M | -26.05%87.83M |
| Add:Non operating Income | -60.75%797.82K | 13.94%788.21K | -89.23%74.48K | ---- | 159.16%2.03M | -14.63%691.78K | -15.93%691.43K | ---- | -49.71%784.42K | -42.05%810.35K |
| Less:Non operating expense | 1.34%742.81K | -14.43%66.14K | 87.63%65.7K | 59.14%55.7K | -61.70%732.98K | -90.93%77.3K | -95.59%35.01K | --35K | 200.94%1.91M | 68.31%851.85K |
| Total profit | 15.58%192.21M | 6.33%146.17M | 5.18%96.6M | 6.19%48.52M | 14.58%166.31M | 56.59%137.46M | 91.58%91.84M | 274.57%45.69M | -7.11%145.15M | -26.63%87.79M |
| Less:Income tax cost | 39.50%60.47M | 15.06%41.22M | 12.30%26.04M | 20.46%12.78M | 22.21%43.34M | 153.09%35.82M | 247.62%23.19M | 448.13%10.61M | -23.45%35.47M | -37.57%14.15M |
| Net profit | 7.14%131.75M | 3.26%104.95M | 2.78%70.56M | 1.87%35.74M | 12.11%122.96M | 38.04%101.64M | 66.36%68.65M | 241.82%35.08M | -0.21%109.68M | -24.08%73.63M |
| Net profit from continuing operation | 7.14%131.75M | 3.26%104.95M | 2.78%70.56M | 1.87%35.74M | 12.11%122.96M | 38.04%101.64M | 66.36%68.65M | 241.82%35.08M | -0.21%109.68M | -24.08%73.63M |
| Less:Minority Profit | -3,362.13%-443.33K | -6,217.10%-142.48K | -365.43%-24.27K | -383.74%-17.52K | 99.84%-12.81K | 79.73%-2.26K | 68.56%-5.21K | -219.54%-3.62K | 32.53%-7.83M | 99.84%-11.13K |
| Net profit of parent company owners | 7.49%132.19M | 3.39%105.09M | 2.80%70.58M | 1.91%35.75M | 4.65%122.97M | 38.02%101.64M | 66.30%68.66M | 241.96%35.08M | -3.30%117.51M | -29.02%73.64M |
| Earning per share | ||||||||||
| Basic earning per share | 4.76%0.22 | 5.88%0.18 | 9.09%0.12 | 0.00%0.08 | -19.23%0.21 | 6.25%0.17 | 22.22%0.11 | 166.67%0.08 | -29.73%0.26 | -50.00%0.16 |
| Diluted earning per share | 4.76%0.22 | 5.88%0.18 | 9.09%0.12 | 0.00%0.08 | -19.23%0.21 | 6.25%0.17 | 22.22%0.11 | 166.67%0.08 | -29.73%0.26 | -50.00%0.16 |
| Other composite income | ||||||||||
| Total composite income | 7.14%131.75M | 3.26%104.95M | 2.78%70.56M | 1.87%35.74M | 12.11%122.96M | 38.04%101.64M | 66.36%68.65M | 241.82%35.08M | -0.21%109.68M | -24.08%73.63M |
| Total composite income of parent company owners | 7.49%132.19M | 3.39%105.09M | 2.80%70.58M | 1.91%35.75M | 4.65%122.97M | 38.02%101.64M | 66.30%68.66M | 241.96%35.08M | -3.30%117.51M | -29.02%73.64M |
| Total composite income of minority owners | -3,362.13%-443.33K | -6,217.10%-142.48K | -365.43%-24.27K | -383.74%-17.52K | 99.84%-12.81K | 79.73%-2.26K | 68.56%-5.21K | -219.54%-3.62K | 32.53%-7.83M | 99.84%-11.13K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Zhonghui Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhonghui Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhonghui Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.